Inside Innovation

Seattle-based InBios International, a biotech focused on the development of diagnostic tests for infectious diseases, received a $16.5 million award from the Biomedical Advanced Research

Intrinsic Medicine, a Seattle-based biotech, is developing human milk oligosaccharide (HMO) drugs to treat a range of gut immune microbiota brain axis disorders, with its

LSW members RareCyte and Alpenglow Biosciences were ranked among the top 10 spatial biology companies of 2024. In June, RareCyte completed a $20 million financing

Dr. Ingrid Swanson Pultz, a trailblazer in protein design, began her career at the University of Washington with a passion for creating innovative biological solutions.

Healionics, a medical technology company headquartered in Seattle, announced that its STARgraft arteriovenous (AV) graft for dialysis access has received Breakthrough Device designation from the

Derrick Hicks, Ph.D., a researcher in the Baker lab at the University of Washington’s Institute for Protein Design (IPD), has received a $387,050 grant by

Tune Therapeutics, a Seattle-based biotech company, is developing a groundbreaking approach to cure hepatitis B (HBV) by deactivating viral genes without damaging human DNA. The

Three Fred Hutch Cancer Center researchers have received over $4 million in grants from the Washington Research Foundation to advance immunotherapies for Merkel cell carcinoma,

AGC Biologics, led by new CEO Alberto Santagostino, plans to scale and strengthen its reputation as a customer-friendly, expert-driven CDMO. Building on AGC Biologics’ extensive

LumiThera, a Poulsbo-based medical device company specializing in ocular disease treatments, has received FDA clearance for the first-ever light-based therapy for dry age-related macular degeneration

The University of Washington infused $20.9 billion into Washington state’s economy last year, with UW Medicine accounting for $12.5 billion through its support of 60,700